関連する実験動画
Updated: Sep 9, 2025
10:20
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
20.9K
α- と δ- トコトリエノールがヒトの呼吸道滑らかな筋肉細胞に及ぼす影響 ~ トコトリエノールが喘息における呼吸道改造治療の潜在的な候補として
Ryota Okazaki1, Aditya Sri Listyoko1, Tomoya Harada1
1Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University.
Journal of nutritional science and vitaminology
|August 31, 2025
まとめ
アルファ・デルタ・トコトリエノールは,ビタミンEの化合物で,呼吸道滑らかな筋肉細胞の増殖と移動を阻害する. これらの効果はRhoA経路と減少反応性酸素種によって媒介され,喘息の管理に役割を果たすことを示唆しています.
科学分野:
- 生物化学
- 細胞生物学
- 薬理学について
背景:
- ビタミンEの一種であるトコトリエノールには,抗酸化,免疫調節,および抗炎症性があります.
- 以前の研究では,ガンマトコトリエノールがRhoA活性化を抑制することで,呼吸道滑らかな筋肉 (ASM) 細胞の増殖と移動を抑制することが示されました.
- 喘息の呼吸道改造はASM細胞の増殖,移住,収縮性フェノタイプ発現を伴う.
研究 の 目的:
- ヒトASM細胞における成長因子β1 (TGF-β1) 誘発の収縮性フェノタイプ発現に対するアルファおよびデルタトコトリエノールの影響を調査する.
- アルファとデルタトコトリエノールが血小板由来成長因子BB (PDGF-BB) によって誘発されるASM細胞の増殖と移動を調節するかどうかを判断する.
- これらの調節効果に関与するシグナル伝達経路を解明する.
主な方法:
- 人間のASM細胞はアルファまたはデルタトコトリエノールで前処理された.
- 細胞はPDGF-BBで増殖/移動を誘発したり,TGF-β1で滑らかな筋肉のアクチン発現を誘発したりした.
- 増殖,移動,アルファ滑らかな筋肉のアクチン発現,RhoA活性化,および活性酸素種 (ROS) 産生を評価した.
主要な成果:
- TGF-β1は,アルファ滑らかな筋肉のアクチン発現を増加させ,アルファとデルタトコトリエノールは,非有意な減少を示した.
- PDGF- BB誘発のASM細胞の増殖と移動は,アルファとデルタトコトリエノールによって有意に抑制された.
- 抑制効果はRhoAシグナル伝達経路とROSの産生を減少させた.
結論:
- アルファとデルタトコトリエノールは,PDGF-BB誘発によるヒトASM細胞の増殖と移動を有意に抑制する.
- これらのトコトリエノールは,喘息の呼吸道改造に有益な効果を発揮する可能性があります.
- このメカニズムはRhoA経路とROS生成の調節を伴う.
関連する概念動画
01:19Antiasthma Drugs: Leukotriene Modifiers
461
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
461
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
377
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
377
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
449
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
449
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451